MedTech News
Graphene technology matures brain organoids faster, may unlock neurodegenerative insights
Researchers from the University of California San Diego Sanford Stem Cell Institute have developed a novel method to stimulate and mature human brain organoids using graphene, a one-atom-thick sheet of carbon.
A boost for the precision of genome editing
Researchers develop a fast-acting, cell-permeable protein system to control CRISPR-Cas9, reducing off-target effects and advancing gene therapy.
Health Canada grants licence to Cepheid’s HCV test
Cepheid announced that the test will be shipped to Canadian customers this month.
Signos gets FDA green light for over-the-counter CGM for weight management
Signos today announced a major step forward in bringing over-the-counter (OTC) continuous glucose monitoring (CGM) to market.
Microbot Medical earns new surgical robot patent
Microbot Medical (Nasdaq:MBOT) announced today that it received a new patent covering a modular robotic surgical system.
Innovation in the Fight Against Parkinson’s: Stimvia’s Non-Invasive URIS® Therapy Shows Success in Clinical Study
OSTRAVA, Czech Republic, Aug. 19, 2025 /PRNewswire/ — Stimvia, a medtech company based in the Czech Republic, has successfully completed a clinical study on peroneal electrical transcutaneous neuromodulation (peroneal eTNM®) through its URIS® device to treat Parkinson’s disease symptoms.
DTSS’s acoustic innovation addresses the healthcare application market projected to exceed $100 billion in China and approach $90 billion globally by 2030
Datasea, a Nevada-based technology enterprise specialising in advanced acoustic high-tech products and AI multimodal digital solutions, today announced a milestone breakthrough in its acoustic technology
Machine learning model maps West Nile virus risk in Northeast US
West Nile virus (WNV) has been the dominant cause of mosquito-borne illness in the United States since its introduction into North America in 1999. There are no vaccines nor medications to prevent or treat illness in people, so surveillance, prevention, and control remain the best options to protect the public.